Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase NA 2Phase 2 2Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 8cyclopia sequence 6Prostatic Neoplasms 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Urinary Bladder Neoplasms 2Polycystic Ovary Syndrome 2Pancreatic Neoplasms 2Neoplasms, Plasma Cell 2Neoplasms 2Neoplasm Metastasis 2Multiple Myeloma 2Hematologic Diseases 2Head and Neck Neoplasms 2Fatigue 2Warts 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Intraepithelial Neoplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Papilloma 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Neuromyelitis Optica 1Myelitis, Transverse 1Myelitis 1Melanoma 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Sugars × Clear all
NCT01238120 2021-05-05

The Effects of Physical Activity and Low-Dose Ibuprofen on Cognitive Function in Cancer Patients

University of Rochester

Phase 2 Completed
110 enrolled 15 charts
Tumor-Agnostic

Neoplasms

NCT00178373 2015-12-23

Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

University of Rochester

Phase 2 Completed
96 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡